Literature DB >> 8642694

Mutational analysis of the vaccinia virus E3 protein defines amino acid residues involved in E3 binding to double-stranded RNA.

C K Ho1, S Shuman.   

Abstract

Alanine-substitution mutations were targeted to 14 amino acid residues within the double-stranded (ds) RNA binding motif (dsRBM) of the vaccinia virus E3 protein. Substitutions at six positions--Glu-124, Phe-135, Phe-148, Lys-167, Arg-168, and Lys-171--caused significant reductions in dsRNA binding. These six residues are conserved in the two dsRBMs for which structural information is available (Escherichia coli RNase III and Drosophila melanogaster staufen) and in many other members of the dsRBM protein family. Residues we show to be important for dsRNA binding by vaccinia virus E3 map to the same face of the dsRBM structure and are thus likely to compose part of the RNA binding site.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642694      PMCID: PMC190110     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  Mechanism of interferon action: identification of a RNA binding domain within the N-terminal region of the human RNA-dependent P1/eIF-2 alpha protein kinase.

Authors:  S J McCormack; D C Thomis; C E Samuel
Journal:  Virology       Date:  1992-05       Impact factor: 3.616

2.  A conserved double-stranded RNA-binding domain.

Authors:  D St Johnston; N H Brown; J G Gall; M Jantsch
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

3.  Proteolytic cleavage of the reovirus sigma 3 protein results in enhanced double-stranded RNA-binding activity: identification of a repeated basic amino acid motif within the C-terminal binding region.

Authors:  J E Miller; C E Samuel
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

4.  Use of T7 RNA polymerase to direct expression of cloned genes.

Authors:  F W Studier; A H Rosenberg; J J Dunn; J W Dubendorff
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

5.  Phenotypic selection and characterization of mutant alleles of a eukaryotic DNA topoisomerase I.

Authors:  S G Morham; S Shuman
Journal:  Genes Dev       Date:  1990-04       Impact factor: 11.361

6.  Characterization of a vaccinia virus-encoded double-stranded RNA-binding protein that may be involved in inhibition of the double-stranded RNA-dependent protein kinase.

Authors:  J C Watson; H W Chang; B L Jacobs
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

7.  Identification of a conserved motif that is necessary for binding of the vaccinia virus E3L gene products to double-stranded RNA.

Authors:  H W Chang; B L Jacobs
Journal:  Virology       Date:  1993-06       Impact factor: 3.616

8.  3'-terminal labelling of RNA with T4 RNA ligase.

Authors:  T E England; O C Uhlenbeck
Journal:  Nature       Date:  1978-10-12       Impact factor: 49.962

9.  Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR.

Authors:  A Gatignol; A Buckler-White; B Berkhout; K T Jeang
Journal:  Science       Date:  1991-03-29       Impact factor: 47.728

10.  The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase.

Authors:  H W Chang; J C Watson; B L Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

View more
  18 in total

1.  Loss of protein kinase PKR expression in human HeLa cells complements the vaccinia virus E3L deletion mutant phenotype by restoration of viral protein synthesis.

Authors:  Ping Zhang; Bertram L Jacobs; Charles E Samuel
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

2.  The double-stranded RNA binding domain of the vaccinia virus E3L protein inhibits both RNA- and DNA-induced activation of interferon beta.

Authors:  Jean-Baptiste Marq; Stéphane Hausmann; Jeremy Luban; Daniel Kolakofsky; Dominique Garcin
Journal:  J Biol Chem       Date:  2009-07-07       Impact factor: 5.157

3.  Mutational analysis of vaccinia virus E3 protein: the biological functions do not correlate with its biochemical capacity to bind double-stranded RNA.

Authors:  Kevin J Dueck; YuanShen Sandy Hu; Peter Chen; Yvon Deschambault; Jocelyn Lee; Jessie Varga; Jingxin Cao
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

4.  Comparative analysis of poxvirus orthologues of the vaccinia virus E3 protein: modulation of protein kinase R activity, cytokine responses, and virus pathogenicity.

Authors:  Chad Myskiw; Janilyn Arsenio; Craig Hammett; Rebekah van Bruggen; Yvon Deschambault; Nicole Beausoleil; Shawn Babiuk; Jingxin Cao
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

5.  Regulation of PACT-Mediated Protein Kinase Activation by the OV20.0 Protein of Orf Virus.

Authors:  Yeu-Yang Tseng; Guan-Ru Liao; Ganes C Sen; Fong-Yuan Lin; Wei-Li Hsu
Journal:  J Virol       Date:  2015-09-09       Impact factor: 5.103

6.  Inhibition of PKR activation by the proline-rich RNA binding domain of the herpes simplex virus type 1 Us11 protein.

Authors:  J Poppers; M Mulvey; D Khoo; I Mohr
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

7.  Activation of the beta interferon promoter by unnatural Sendai virus infection requires RIG-I and is inhibited by viral C proteins.

Authors:  Laura Strähle; Jean-Baptiste Marq; Albert Brini; Stéphane Hausmann; Daniel Kolakofsky; Dominique Garcin
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

8.  Baculovirus protein PK2 subverts eIF2α kinase function by mimicry of its kinase domain C-lobe.

Authors:  John J Li; Chune Cao; Sarah M Fixsen; Janet M Young; Chikako Ono; Hisanori Bando; Nels C Elde; Susumu Katsuma; Thomas E Dever; Frank Sicheri
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-27       Impact factor: 11.205

9.  Induction of protein kinase PKR-dependent activation of interferon regulatory factor 3 by vaccinia virus occurs through adapter IPS-1 signaling.

Authors:  Ping Zhang; Charles E Samuel
Journal:  J Biol Chem       Date:  2008-10-15       Impact factor: 5.157

10.  Vaccinia virus E3 suppresses expression of diverse cytokines through inhibition of the PKR, NF-kappaB, and IRF3 pathways.

Authors:  Chad Myskiw; Janilyn Arsenio; Rebekah van Bruggen; Yvon Deschambault; Jingxin Cao
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.